GSK-LSD1 (hydrochloride)


  • Specification
  • Related Products
Cat.No.:  BSM-0321
Product Name:  GSK-LSD1 (hydrochloride)
Figure: 
Product Overview:  An LSD1 inhibitor
Description:  Lysine-specific demethylase 1 (LSD1) belongs to the family of flavin adenine dinucleotide (FAD)-dependent amine oxidases that include monoamine oxidases (MAOs) and polyamine oxidase (PAO). LSD1 specifically demethylates mono- and dimethylated histone H3 lysine 4, resulting in transcriptional repression. It also controls the tumor suppressor activity of p53 by demethylating a specific p53 lysine residue (LYS370). GSK-LSD1 is an irreversible, mechanism-based inhibitor of LSD1 (IC50 = 16 nM) that is >1,000-fold selective over the closely related FAD-utilizing enzymes LSD2, MAO-A, and MAO-B. GSK-LSD1 induces gene expression changes in various cancer cell lines, inhibiting their proliferation (EC50s <5 nM).
Appearance:  A crystalline solid
Molecular Weight:  289.2
Purity:  ≥98%
Storage:  -20°C
Targets:  LSD1
Molecular Formula:  C14H20N2 • 2HCl
Chemical Name:  N-[(1R,2S)-2-phenylcyclopropyl]-4-piperidinamine, dihydrochloride
Warning:  For Research Use Only! Not For Use in Humans.

Online Inquiry

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

USA

Enter your email here to subscribe.

Follow us on

Easy access to products and services you need from our library via powerful searching tools

Copyright © Creative BioMart. All Rights Reserved.